Hagersten, Sweden

Goran Mattias Wennerstal

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Goran Mattias Wennerstal

Introduction

Goran Mattias Wennerstal is an accomplished inventor based in Hagersten, Sweden. With a total of four patents to his name, Wennerstal has made significant contributions to the field of pharmaceuticals, particularly in the modulation of specific biological activities that can lead to innovative treatment methods for various medical disorders.

Latest Patents

Wennerstal's latest patents include two groundbreaking inventions:

1. **Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof** - This invention introduces methyl- and trifluoromethyl-substituted pyrrolopyridines, along with their pharmaceutical compositions. The methods outlined in this patent focus on modulating RORγ activity and reducing the amount of IL-17 in a subject, providing potential treatments for diverse medical disorders.

2. **Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof** - This patent encompasses sulfonamide-substituted indoles, showcasing methods that regulate RORγ activity and lower IL-17 levels in a subject. These advancements offer promising options for treating various medical conditions.

Career Highlights

Goran Mattias Wennerstal is currently associated with Pfizer Corporation, a leading pharmaceutical company, where he collaborates on innovative research projects. His expertise has led to advancements in the understanding and treatment of important medical conditions through chemical modulation.

Collaborations

Throughout his career, Wennerstal has worked alongside notable colleagues such as Mark E. Schnute and Andrew Christopher Flick. These collaborations have facilitated the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Goran Mattias Wennerstal's contributions to pharmaceutical innovations exemplify the vital role of inventors in advancing medical science. His patents stand as a testament to his commitment to enhancing healthcare through the development of novel treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…